Fig. 2From: The ENGAGE study: a 3-arm randomized hybrid type 1 effectiveness and implementation study of an in-home, collaborative PCP model of remote telegenetic services to increase uptake of cancer genetic services in childhood cancer survivorsRandomized study schema. *6-Month Outcome Survey also given to participants on Arms A and B that have lost contact with Penn Telegenetics before receiving genetic services; participants in Arms A and B who have not had genetic services can still receive services according to their randomized armBack to article page